Technology
Health
Biotechnology

INmune Bio

351

$6.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (1.67%) As of 4:00 PM EDT pre-market
+$0.10 (1.67%) Pre-Market

Why Robinhood?

You can buy or sell INmune Bio and other stocks, options, ETFs, and crypto commission-free!

About INMB

INmune Bio Inc. Common stock, also called INmune Bio, is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. Read More Its products include INKMUNE and INB03. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.

CEO
Raymond J. Tesi
Employees
3
Headquarters
La Jolla, California
Founded
2015
Market Cap
65.88M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
23.64K
High Today
$6.12
Low Today
$5.98
Open Price
$6.05
Volume
10.09K
52 Week High
$11.50
52 Week Low
$5.06

Collections

Technology
Health
Biotechnology
Medical
Cancer Prevention
2019 IPO
US
North America

INMB Earnings

-$0.20
-$0.20
-$0.19
-$0.19
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 14, Pre-Market
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy INMB

Market Price$6.10
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell INmune Bio stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up